115 related articles for article (PubMed ID: 8406126)
21. [A respiratory splash of monocytes and neutrophils in familial Mediterranean fever].
Davtian TK; Avetisian SA; Akopian GS; Arutiunian VM
Ter Arkh; 2005; 77(12):39-43. PubMed ID: 16514818
[TBL] [Abstract][Full Text] [Related]
22. Acute phase response and oxidative stress status in familial Mediterranean fever (FMF).
Guzel S; Andican G; Seven A; Aslan M; Bolayirli M; Guzel EC; Hamuryudan V
Mod Rheumatol; 2012 Jun; 22(3):431-7. PubMed ID: 21947799
[TBL] [Abstract][Full Text] [Related]
23. Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis.
Emerit I
Free Radic Biol Med; 1994 Jan; 16(1):99-109. PubMed ID: 8300000
[TBL] [Abstract][Full Text] [Related]
24. Simple markers for subclinical inflammation in patients with Familial Mediterranean Fever.
Özer S; Yılmaz R; Sönmezgöz E; Karaaslan E; Taşkın S; Bütün İ; Demir O
Med Sci Monit; 2015 Jan; 21():298-303. PubMed ID: 25615955
[TBL] [Abstract][Full Text] [Related]
25. Liver involvement in children with Familial Mediterranean fever.
Unal F; Cakir M; Baran M; Arıkan C; Yuksekkaya HA; Aydoğdu S
Dig Liver Dis; 2012 Aug; 44(8):689-93. PubMed ID: 22333476
[TBL] [Abstract][Full Text] [Related]
26. Is the genotoxic effect of arsenic mediated by oxygen free radicals?
Nordenson I; Beckman L
Hum Hered; 1991; 41(1):71-3. PubMed ID: 2050385
[TBL] [Abstract][Full Text] [Related]
27. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health.
Samuels J; Aksentijevich I; Torosyan Y; Centola M; Deng Z; Sood R; Kastner DL
Medicine (Baltimore); 1998 Jul; 77(4):268-97. PubMed ID: 9715731
[TBL] [Abstract][Full Text] [Related]
28. Incidence of familial Mediterranean fever (FMF) mutations among children of Mediterranean extraction with functional abdominal pain.
Brik R; Litmanovich D; Berkowitz D; Shamir R; Rosenthal E; Shinawi M; Gershoni-Baruch R
J Pediatr; 2001 May; 138(5):759-62. PubMed ID: 11343058
[TBL] [Abstract][Full Text] [Related]
29. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
Omma A; Sandikci SC; Kücüksahin O; Alisik M; Erel O
J Korean Med Sci; 2017 Oct; 32(10):1588-1594. PubMed ID: 28875601
[TBL] [Abstract][Full Text] [Related]
30. Induction of chromosomal aberrations and sister chromatid exchanges by chlormadinone acetate in human lymphocytes: a possible role of reactive oxygen species.
Siddique YH; Afzal M
Indian J Exp Biol; 2004 Nov; 42(11):1078-83. PubMed ID: 15587113
[TBL] [Abstract][Full Text] [Related]
31. Is the IL-6 -174G/C Gene Polymorphism Related to the Disease Severity Score in Turkish Children with Familial Mediterranean Fever?
Özer S; Yilmaz R; Sonmezgoz E; Ünuvar Ş; Ates Ö
Biochem Genet; 2016 Dec; 54(6):886-893. PubMed ID: 27476063
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of subclinical inflammation in familial Mediterranean fever patients: relations with mutation types and attack status: a retrospective study.
Kelesoglu FM; Aygun E; Okumus NK; Ersoy A; Karapınar E; Saglam N; Aydın NG; Senay BB; Gonultas S; Sarisik E; Can MZ; Atay S; Basbug D; Tiryaki FK; Ozer S; Durmus RB; Orem F; Atay T; Acar A; Yilmaz Y; Kaya S; Ciftkaya A; Sarac Z; Makar CC; Saracoglu B; Dogdu G; Omeroglu RE
Clin Rheumatol; 2016 Nov; 35(11):2757-2763. PubMed ID: 27106545
[TBL] [Abstract][Full Text] [Related]
33. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study.
Yalçinkaya F; Cakar N; Acar B; Tutar E; Güriz H; Elhan AH; Oztürk S; Kansu A; Ince E; Atalay S; Girgin N; Doğru U; Aysev D; Ekim M
Rheumatol Int; 2007 Apr; 27(6):517-22. PubMed ID: 17103173
[TBL] [Abstract][Full Text] [Related]
34. Formation of a clastogenic factor by asbestos-treated rat pleural mesothelial cells.
Emerit I; Jaurand MC; Saint-Etienne L; Levy A
Agents Actions; 1991 Nov; 34(3-4):410-5. PubMed ID: 1667247
[TBL] [Abstract][Full Text] [Related]
35. Peroxidation of linoleic, arachidonic and oleic acid in relation to the induction of oxidative DNA damage and cytogenetic effects.
de Kok TM; ten Vaarwerk F; Zwingman I; van Maanen JM; Kleinjans JC
Carcinogenesis; 1994 Jul; 15(7):1399-404. PubMed ID: 8033317
[TBL] [Abstract][Full Text] [Related]
36. Genetic linkage study of familial Mediterranean fever (FMF) to 16p13.3 and evidence for genetic heterogeneity in the Turkish population.
Akarsu AN; Saatci U; Ozen S; Bakkaloglu A; Besbas N; Sarfarazi M
J Med Genet; 1997 Jul; 34(7):573-8. PubMed ID: 9222966
[TBL] [Abstract][Full Text] [Related]
37. The effect of plasminogen activator inhibitor-1 -675 4G/5G polymorphism on familial Mediterranean fever (FMF) disease.
Ozel Demiralp D; Ekim M; Akar N
Clin Appl Thromb Hemost; 2009; 15(4):443-7. PubMed ID: 19033264
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of pentraxin-3 in familial Mediterranean fever patients during attack and attack-free periods.
Gok M; Sirkeci O; Kara M; Sakin YS; Tanoglu A; Sirkeci EE; Oztin H; Duzenli T; Kaplan M; Yazgan Y; Ipcioglu OM
Bratisl Lek Listy; 2018; 119(8):490-493. PubMed ID: 30160156
[TBL] [Abstract][Full Text] [Related]
39. [Metabolism of arachidonic acid in the thrombocytes of patients with periodic disease].
Panosian AG; Grigorian SV; Davtian DG; Gevorkian GA; Gabrielian ES
Biull Eksp Biol Med; 1986 Nov; 102(11):561-3. PubMed ID: 3096398
[TBL] [Abstract][Full Text] [Related]
40. Familial Mediterranean fever is no longer a rare disease in Japan.
Migita K; Izumi Y; Jiuchi Y; Iwanaga N; Kawahara C; Agematsu K; Yachie A; Masumoto J; Fujikawa K; Yamasaki S; Nakamura T; Ubara Y; Koga T; Nakashima Y; Shimizu T; Umeda M; Nonaka F; Yasunami M; Eguchi K; Yoshiura K; Kawakami A
Arthritis Res Ther; 2016 Jul; 18():175. PubMed ID: 27473114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
